Novel type of references for BMI aligned for onset of puberty - using the QEPS growth model.

Biological age Personalized growth Pubertal growth SDS Standard reference population

Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
30 04 2022
Historique:
received: 08 12 2021
accepted: 22 04 2022
entrez: 30 4 2022
pubmed: 1 5 2022
medline: 4 5 2022
Statut: epublish

Résumé

Despite inter-individual variations in pubertal timing, growth references are conventionally constructed relative to chronological age (C-age). Thus, they are based on reference populations containing a mix of prepubertal and pubertal individuals, making them of limited use for detecting abnormal growth during adolescence. Recently we developed new types of height and weight references, with growth aligned to age at onset of the pubertal growth spurt (P-age). Here, we aim to develop a corresponding reference for pubertal BMI. The QEPS-height and weight models were used to define a corresponding QEPS-BMI model. QEPS-BMI was modified by the same individual, constitutional weight-height-factor (WHF) as computed for QEPS-weight. QEPS-BMI functions were computed with QEPS weight and height functions fitted on longitudinal measurements from 1418 individuals (698 girls) from GrowUp References (median, standard deviation score (SDS)) were generated for total BMI (QEPS-functions), for ongoing prepubertal growth (QE-function) vs C-age, and for total BMI and separated into BMI specific to puberty (P-function) and BMI gain from ongoing basic growth (QES-functions), allowing individual growth to be aligned based on P-age. Growth in basic BMI was greater than average for children categorized as tall and/or with high-BMI at puberty-start. In children categorized as short at puberty-start, P-function-related-BMI was greater than average. Use of these new pubertal BMI references will make it possible for the first time to consider individual variations owing to pubertal timing when evaluating BMI. This will improve the detection of abnormal changes in body composition when used in combination with pubertal height and weight references also abnormal growth. Other benefits in the clinic will include improved growth monitoring during treatment for children who are overweight/obese or underweight. Furthermore, in research settings these new references represent a novel tool for exploring human growth.

Identifiants

pubmed: 35490220
doi: 10.1186/s12887-022-03304-3
pii: 10.1186/s12887-022-03304-3
pmc: PMC9055717
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

238

Informations de copyright

© 2022. The Author(s).

Références

Acta Paediatr. 2020 Apr;109(4):754-763
pubmed: 31811779
J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2535-e2546
pubmed: 33772303
Acta Paediatr. 2021 Dec;110(12):3349-3355
pubmed: 34464992
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e1-e10
pubmed: 32816013
Pediatr Res. 2008 Jul;64(1):2-7
pubmed: 18652011
BMC Pediatr. 2017 Apr 19;17(1):107
pubmed: 28424059
Wilhelm Roux Arch Entwickl Mech Org. 1940 Jun;140(2):285-314
pubmed: 28354008
J Pediatr Endocrinol Metab. 2012;25(1-2):125-9
pubmed: 22570961
J Pediatr Endocrinol Metab. 2020 Sep 25;33(9):1173-1182
pubmed: 32809956
Am J Clin Nutr. 2002 Jun;75(6):978-85
pubmed: 12036802
J Intern Med. 2018 Jun;283(6):558-567
pubmed: 29532534
Stat Med. 1987 Mar;6(2):185-92
pubmed: 3589247
Int J Eat Disord. 2016 Nov;49(11):1002-1009
pubmed: 27464302
Nutr Rev. 2016 Mar;74(3):149-65
pubmed: 26928678
Eur J Clin Nutr. 2000 Mar;54(3):203-8
pubmed: 10713741
Lancet Diabetes Endocrinol. 2021 Jul;9(7):419-426
pubmed: 33989535
BMC Pediatr. 2021 Nov 13;21(1):507
pubmed: 34774010
J Clin Endocrinol Metab. 2019 May 1;104(5):1823-1832
pubmed: 30517677
Lancet Diabetes Endocrinol. 2017 Mar;5(3):174-183
pubmed: 28065734
Ann Hum Biol. 2012 Sep;39(5):382-94
pubmed: 22780429
Pediatr Res. 2017 Mar;81(3):448-454
pubmed: 27861464
Acta Paediatr. 2001 Dec;90(12):1427-34
pubmed: 11853342
Acta Paediatr. 2021 Feb;110(2):537-548
pubmed: 32654218
Int J Obes (Lond). 2005 Jan;29(1):1-8
pubmed: 15278104
J Theor Biol. 2016 Oct 7;406:143-65
pubmed: 27297288
Hypertension. 2007 Jun;49(6):1415-21
pubmed: 17452506
Early Hum Dev. 2006 Aug;82(8):485-91
pubmed: 16876341
Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):974-979
pubmed: 30842130
Acta Paediatr. 2021 Dec;110(12):3151-3152
pubmed: 34599534
Obesity (Silver Spring). 2013 May;21(5):1018-24
pubmed: 23784906
Acta Paediatr. 2002;91(7):739-54
pubmed: 12200898
Pediatr Obes. 2020 Jul;15(7):e12626
pubmed: 32074662
Ann Hum Biol. 2009 Sep-Oct;36(5):445-58
pubmed: 19562567
Acta Paediatr Scand Suppl. 1987;337:12-29
pubmed: 3481178
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
Arch Dis Child. 1966 Oct;41(219):454-71
pubmed: 5957718
Pediatr Obes. 2012 Aug;7(4):284-94
pubmed: 22715120
Acta Paediatr. 2022 Feb;111(2):225-235
pubmed: 34687241

Auteurs

Kerstin Albertsson-Wikland (K)

Department of Physiology/Endocrinology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, SE 405 30, Gothenburg, Sweden. Kerstin.albertsson.wikland@gu.se.

Aimon Niklasson (A)

Göteborg Pediatric Growth Research Center, Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Lars Gelander (L)

Department of Physiology/Endocrinology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, SE 405 30, Gothenburg, Sweden.

Anton Holmgren (A)

Göteborg Pediatric Growth Research Center, Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Pediatrics, Halmstad Hospital, Halmstad, Sweden.

Andreas F M Nierop (AFM)

Department of Physiology/Endocrinology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, SE 405 30, Gothenburg, Sweden.
Muvara bv, Multivariate Analysis of Research Data, Leiderdorp, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH